X
Jul 02, 2021 10:33 AM (GMT+8) · EqualOcean
Today, Hangzhou meisai Biomedical Technology Co., Ltd. announced the completion of tens of millions of Yuan Angel round of financing. Mercer bio is the first emerging biotechnology company in China to focus on the development of new macrophage target drugs in tumor immune microenvironment. This round of financing is led by Kaifeng venture capital and followed by Danlu capital. The funds raised will be mainly used for the research and development of existing product pipelines and the introduction of high-end talents.